Pfizer, Inc. · NYSE:PFE
Pfizer — Barclays Capital 2012 Global Healthcare Conference
14 slides from Pfizer's conference presentation, Mar 13, 2012
Slide 1: Barclays Capital 2012 Global Healthcare Conference
Barclays Capital 2012 Global Healthcare Conference Pfizer Worldwide Research & Development Mikael Dolsten, M.D., Ph.D. January 27th, 2012 March 13, 2012
Slide 2: Forward-Looking Statements
Forward-Looking Statements Our discussions during this presentation will include forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are discussed in Pfizer’s 2011 Annual Repo
Slide 3: Pfizer R&D Strategy
Pfizer R&D Strategy 3 Major Priorities Delivering the Innovating New R&D Ecosystem Portfolio Capabilities of the Future Sharpening focus in Investing in the Highly networked R&D areas with greatest technologies to enable & superior outcomes in scientific & tomorrow’s products Precision patient comme
Slide 4: Improving R&D Return On Investment
Improving R&D Return On Investment Unlocking Additional Value for Shareholders Three Key Principles 1 2 3 Greater Strategic Differentiated Focus Externalization Innovation Quality Probability Speed Cost of Output of Success Termination of numerous non-core research projects Neusentis (Pain) unit
Slide 5: Today's Key Late-Stage Assets
Today’s Key Late-Stage Assets Key Post-POC Programs Key Products In Registration Bapineuzumab Eliquis™ (apixiban) Alzheimer's Disease Stroke Prevention in AFib; US/EU/Japan Eliquis (apixaban) Tofacitinib VenousThromboembolism Treatment RA; US/EU/Japan Tafamidis meglumine Tofacitinib transthyretin am
Slide 6: Science and Technology Drive Differentiated Programs in Earlier Stages
Science and Technology Drive Differentiated Programs in Earlier Stages Immunology & Inflammation Cardiovascular & Metabolic Diseases Oncology Vaccines Neuroscience & Pain Biosimilars & Orphan & Genetic Diseases 6
Slide 7: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Inflammation Beyond RA: Transforming Chronic Disease IL6, MAdCAM, p38 7
Slide 8: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Inflammation Metabolic Diseases Beyond RA: New Paths to Transforming Chronic Sustained Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 8
Slide 9: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Oncology Inflammation Metabolic Diseases Beyond RA: New Paths to Power of Precision Transforming Chronic Sustained Medicine Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 PI3K/mTOR, CDK4/6, 5T4 9
Slide 10: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Oncology Inflammation Metabolic Diseases Beyond RA: New Paths to Power of Precision Transforming Chronic Sustained Medicine Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 PI3K/mTOR, CDK4/6, 5T4 Vaccines Platform for all Ages an
Slide 11: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Oncology Inflammation Metabolic Diseases Beyond RA: New Paths to Power of Precision Transforming Chronic Sustained Medicine Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 PI3K/mTOR, CDK4/6, 5T4 Vaccines Neuroscience & Pain Plat
Slide 12: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Oncology Inflammation Metabolic Diseases Beyond RA: New Paths to Power of Precision Transforming Chronic Sustained Medicine Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 PI3K/mTOR, CDK4/6, 5T4 Vaccines Neuroscience & Biosimila
Slide 13: Next Wave Pipeline Shapes the Future
Next Wave Pipeline Shapes the Future Immunology & Cardiovascular & Oncology Inflammation Metabolic Diseases Beyond RA: New Paths to Power of Precision Transforming Chronic Sustained Medicine Disease Leadership IL6, MAdCAM, p38 PCSK9, Gka, PDE5 PI3K/mTOR, CDK4/6, 5T4 Vaccines Neuroscience & Biosimila
Slide 14: Q&A
Q&A
Pfizer — Barclays Capital 2012 Global Healthcare Conference on 6ix